Safinamide Products | Cleanchem - An adjunctive treatment for Parkinson's disease that modulates dopamine and glutamate activity. It inhibits monoamine oxidase B and reduces abnormal glutamate release, improving motor function and managing symptoms in Parkinson? patients. It complements existing dopamine-based treatments.

N-Nitroso Safinamide

Cat. No: CL-SAF-NO-01

CAS No: 2657645-00-4

Mol. F: C17H18FN3O3

Mol. Wt: 331.3

Inv. Status: In Stock

N-Nitroso Safinamide Impurity 1

Cat. No: CL-SAF-NO-03

CAS No: NA

Mol. F: C10H13N3O3

Mol. Wt: 223.23

Inv. Status: Custom Synthesis

N-Nitroso Safinamide Impurity 2

Cat. No: CL-SAF-NO-04

CAS No: NA

Mol. F: C17H18FN3O3

Mol. Wt: 331.35

Inv. Status: Custom Synthesis

N-Nitroso Safinamide Impurity 3

Cat. No: CL-SAF-NO-05

CAS No: NA

Mol. F: C23H21F2N3O3

Mol. Wt: 425.44

Inv. Status: Custom Synthesis

N-Nitroso Safinamide Impurity 4

Cat. No: CL-SAF-NO-06

CAS No: NA

Mol. F: C18H19FN2O4

Mol. Wt: 346.36

Inv. Status: In Stock

N-Nitroso Safinamide Impurity 5

Cat. No: CL-SAF-NO-07

CAS No: NA

Mol. F: C17H16FN3O3

Mol. Wt: 329.33

Inv. Status: Custom Synthesis

N-Nitroso Safinamide Impurity 6

Cat. No: CL-SAF-NO-08

CAS No: NA

Mol. F: C17H17FN2O4

Mol. Wt: 332.33

Inv. Status: In Stock

N-Nitroso Safinamide Impurity 7

Cat. No: CL-SAF-NO-09

CAS No: NA

Mol. F: C24H23F2N3O3

Mol. Wt: 439.46

Inv. Status: Custom Synthesis

N-Nitroso Safinamide Impurity 8

Cat. No: CL-SAF-NO-10

CAS No: NA

Mol. F: C17H18FN3O3

Mol. Wt: 331.35

Inv. Status: Custom Synthesis